Based on its own powerful viral vector technology research and development technology platform and rich viral vector production process development experience, Yuanxing Gene is committed to continuously providing more professional and fast CDMO services for new viral vectors at home and abroad.

Yuanxing Gene is willing to develop fair and open cooperation with innovative drug research and development institutions at home and abroad to jointly promote innovative drugs from the laboratory to the market, benefiting the vast number of patients in urgent need of treatment.